Publications

5891 Results

Evaluation of prostate-specific antigen declines for surrogacy in patients treated on SWOG 99-16

Authors
D Petrylak;D Pauler Ankerst;CS Jiang;CM Tangen;MHA Hussain;PN Lara;JA Jones;ME Taplin;PA Burch;M Kohli;MC Benson;EJ Small;D Raghavan;ED Crawford
Journal / Conference
Journal of the National Cancer Institute 98(8):516-521
Year
2006
Research Committee(s)
Genitourinary
Study Number(s)
S9916

Impact of the year 2000 medicare policy change on older patient enrollment to cancer clinical trials

Authors
JM Unger;CA Coltman Jr;JJ Crowley;L Hutchins;S Martino;R Livingston;J Macdonald;C Blanke;D Gandara;ED Crawford;KS Albain
Journal / Conference
Journal of Clinical Oncology 24(1):141-144
Year
2006

The prostate cancer prevention trial: design, biases, and interpretation of study results

Authors
PJ Goodman;IM Thompson Jr;CM Tangen;JJ Crowley;LG Ford;CA Coltman Jr
Journal / Conference
Journal of Urology 175:2234-2242
Year
2006
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Sequential vinorelbine and docetaxel in advanced non-small cell lung cancer patients age 70 and older and/or with a performance status of 2: a phase II trial of the Southwest Oncology Group (S0027)

Authors
PJ Hesketh;K Chansky;DHM Lau;JH Doroshow;CM Moinpour;RA Chapman;JW Goodwin;HM Gross;JJ Crowley;DR Gandara
Journal / Conference
Journal of Thoracic Oncology 1(6):537-544
Year
2006
Research Committee(s)
Lung
Study Number(s)
S0027

Locally advanced prostate cancer treated with concomitant radiation and 5-fluorouracil: Southwest Oncology Group study 9024

Authors
GP Swanson;J Faulkner;SR Smalley;MJ Noble;RL Stephens;TJ O'Rourke;GR Weiss;DP Quick;IM Thompson, Jr;ED Crawford
Journal / Conference
Journal of Urology 176:548-553
Year
2006
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9024

Gefitinib therapy in advanced bronchioloalveolar carcinoma: Southwest Oncology Group study S0126

Authors
HL West;WA Franklin;J McCoy;P Gumerlock;R Vance;DHM Lau;K Chansky;JJ Crowley;DR Gandara
Journal / Conference
Journal of Clinical Oncology 24(12):1807-1813
Year
2006
Research Committee(s)
Lung
Study Number(s)
S0126

Concurrent chemotherapy plus cetuximab or chemotherapy followed by cetuximab in advanced non-small cell lung cancer (NSCLC): a randomized phase II selectional trial SWOG 0342

Authors
K Kelly;RS Herbst;JJ Crowley;J McCoy;JN Atkins;PN Lara;SR Dakhil;KS Albain;ES Kim;DR Gandara
Journal / Conference
Proc of the ASCO, Journal of Clinical Oncology 24(18S):#7015
Year
2006
Research Committee(s)
Lung
Study Number(s)
S0342

MGMT methylation in newly-diagnosed glioblastoma multiforme (GBM): from the S0001 phase III study of radiation therapy (RT) and O-benzylguanine, (O BG) plus BCNU versus RT and BCNU alone for newly diagnosed GBM.

Authors
DT Blumenthal;M Wade;C Rankin;F Fitzpatrick;K Stelzer;A Sloan;W Ackerley;EJ Rushing
Journal / Conference
Proc of the ASCO, Journal of Clinical Oncology 24(18S):#1512
Year
2006
Research Committee(s)
Brain
Study Number(s)
S0001

Alternative measures predicting clinical benefit in advanced non-small cell lung cancer (NSCLC) from Southwest Oncology Group (SWOG) randomized trials: implications for clincial trial design

Authors
PN Lara;MW Redman;K Kelly;MJ Edelman;SK Williamson;JJ Crowley;DR Gandara
Journal / Conference
Proc of the ASCO, Journal of Clinical Oncology 24(18S):#7006
Year
2006
Research Committee(s)
Lung
Study Number(s)
S0003, SWOG-9509, S9806

SWOG 0012, a randomized phase III comparison of standard doxorubicin (A) and cyclophosphamide (C) followed by weekly paclitaxel (T) versus weekly doxorubicin and daily oral cyclophosphamide plus G-CSF (G) followed by weekly paclitaxel as neoadjuvant therapy for inflammatory and locally advanced breast cancer

Authors
GK Ellis;SJ Green;CA Russell;ME Royce;EA Perez;RB Livingston
Journal / Conference
Proc of the ASCO, Journal of Clinical Oncology 24(18S):#LBA537
Year
2006
Research Committee(s)
Breast
Study Number(s)
S0012